Jason Pontin
InvestorGeneral Partner at DCVC (Data Collective)
Palo Alto, California
Writes $5M β $25M checks Β· typically $15M
About
Jason Pontin is a General Partner at DCVC focused on early-stage computational biology and chemistry startups, having joined in 2021 after serving as Senior Partner at Flagship Pioneering. He cofounded Totus Medicines and previously ran media companies, serving as Editor in Chief and Publisher of MIT Technology Review from 2004 to 2017.
Invests in
AI & Machine LearningBiotechClimate Tech
Experience
- DCVCGeneral Partnercurrent2023 β presentPalo Alto, California, United States
- DCVCPartner2021 β 2023
- University of CambridgeGlobal Advisory Board, Cambridge Innovation Hubcurrent2026 β presentCambridge
- ProximaBoard Membercurrent2026 β presentNew York, United States
- Dayhoff LabsBoard Membercurrent2025 β presentLondon Area, United Kingdom
- Kanvas BiosciencesBoard Chaircurrent2023 β presentPrinceton, New Jersey, United States
- Relation TherapeuticsBoard Membercurrent2022 β presentLondon, England, United Kingdom
- Totus MedicinesFounding Board Member, Cofounder, and Initial Investor (through Social Impact Capital)current2019 β presentGreater Boston Area
- WIREDContributing Writercurrent2018 β present
- Evonetix LtdBoard Member2021 β 2026Cambridge
- RecycleyeBoard Member2023 β 2026Greater London
- ZwitterCoBoard Chair2022 β 2026Boston, MA
- Aquafortus TechnologiesBoard Member2023 β 2026Auckland, New Zealand
- DVLP MedicinesBoard Chair2022 β 2025Boston, Massachusetts, United States
- Equilibr.io IncBoard Chair2021 β 2025Palo Alto, California, United States
- StrateosBoard Chair2021 β 2024Menlo Park, California, United States
- Adlai Nortye Biopharma Co., Ltd.Scientific Advisory Board Member2020 β 2023Boston
- Menten AIBoard Observer and Seed Investor (through Social Impact Capital)2020 β 2022Greater Boston
- Flagship PioneeringSenior Advisor2019 β 2020Greater Boston Area
- Flagship PioneeringSenior Partner2018 β 2019Cambridge, MA
Education
- University of OxfordBA, MA (Oxon)1986 β 1989
- Harrow School1980 β 1985
Skills & more
+12 more
Content ManagementBloggingOnline PublishingContent StrategyPhotographyWeb ContentSocial MediaNewspapersContent DevelopmentPublic SpeakingWritingPublic RelationsLanguages Latin, French, a little modern and ancient Greek.
From Jason's professional profile.
Same school
Also attended University of Oxford745
+ 739 more
Also attended Harrow School9
+ 3 more
Shared employers
Also worked at DCVC42
+ 36 more
Also worked at Aquafortus Technologies1
Also worked at MIT Technology Review325
+ 319 more
Deals Β· 5
Proxima BioBoard seat
via DCVC (Data Collective) Β· filed Jun 2026 Β· $91.5M raise
Relation Therapeutics Inc.Board seat
via DCVC (Data Collective) Β· filed Dec 2025 Β· $36.2M raise
Kanvas Biosciences, Inc.Board seat
via DCVC (Data Collective) Β· filed Jun 2023 Β· $12M raise
TatioBoard seat
via DCVC (Data Collective) Β· filed Nov 2022 Β· $2.5M raise
ZwitterCoBoard seat
via DCVC (Data Collective) Β· filed May 2022 Β· $33.4M raise
Attribution from SEC filings, press coverage, and firm rosters.
Colleagues at DCVC (Data Collective)
Network6
Investors connected to Jason in public investor directories β a warm-intro map.




















.webp)











)